Image: BioXconomyEbola Vaccine Trials Launch in DRC and Uganda
• Regulators from the AMA and EMA have launched clinical trials in the Democratic Republic of the Congo and Uganda to combat the Bundibugyo Ebola virus. • The trials will test three vaccines—including mRNA, modified VSV, and ChAdOx1 adenovirus options—alongside various monoclonal antibody treatments and antiviral drugs. • This initiative is critical because, unlike the Zaire Ebola strain, there are currently no approved vaccines or medical treatments available for the Bundibugyo virus.
bioxconomy.com